My impression is that since the Cochrane report on tamiflu, and subsequent BARDA pull out of LANI, nobody is interested. Certainly the company has gone very quiet on it - no mention in their annual report. At a guess, probability of LANI going anywhere would be approaching zero.
Seems appropriate course of action, at this time, is to attempt to sell everything and return all funds to shareholders.
